Thu, August 9, 2012
[ Thu, Aug 09th 2012 ] - Market Wire
NuPathe to Report Second Quarter 2012 Results and Hold Conference Call on Tuesday, August 14, 2012
[ Thu, Aug 09th 2012 ] - Market Wire
Cytomedix to Host Second Quarter 2012 Financial R .. lts Conference Call on Wednesday, August 15, 2012
[ Thu, Aug 09th 2012 ] - Market Wire
Sun Healthcare Group, Inc. Announces Expiration o .. eriod in Connection With Proposed Transaction Wit
[ Thu, Aug 09th 2012 ] - Market Wire
Oncothyreon Reports Second Quarter 2012 Financial Results
[ Thu, Aug 09th 2012 ] - Market Wire
Department of Defense Exercises Options Under Con .. ct for Nerve Agent Medical Countermeasure Program
[ Thu, Aug 09th 2012 ] - Market Wire
Mesa Labs Reports 25% Increase in First Quarter Net Income
[ Thu, Aug 09th 2012 ] - Market Wire
Hospira Announces U.S. Re-Launch Of Generic Oxaliplatin Injection
[ Thu, Aug 09th 2012 ] - Market Wire
Cynosure to Present at Canaccord Genuity 32nd Annual Growth Conference
[ Thu, Aug 09th 2012 ] - Market Wire
Cytori Expands European Approval for Celution(R) .. ncluding Intractable Cryptoglandular Fistulae;
[ Thu, Aug 09th 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
[ Thu, Aug 09th 2012 ] - Market Wire
Fanapta" is Granted Market Approval in Israel for the Treatment of Schizophrenia
Wed, August 8, 2012
[ Wed, Aug 08th 2012 ] - Market Wire
Nordion Statement on Voluntary Disclosure
[ Wed, Aug 08th 2012 ] - Market Wire
Liazon's Private Exchange Expands Aetna Offerings in Key Markets
[ Wed, Aug 08th 2012 ] - Market Wire
MEI Pharma to Acquire Pracinostat, a Potential Best-in-Class HDAC Inhibitor
[ Wed, Aug 08th 2012 ] - Market Wire
Syneron to Present at the Canaccord Genuity Growth Conference
[ Wed, Aug 08th 2012 ] - Market Wire
Lightlake Therapeutics Inc. Announces Positive Fi .. Trial Results of Binge Eating Disorder Treatment
[ Wed, Aug 08th 2012 ] - Market Wire
AspenBio Pharma to Provide Shareholders with Business Update
[ Wed, Aug 08th 2012 ] - Market Wire
Equity Research on Raptor Pharmaceuticals Corp. a .. s Inc. - Strong Quarter for Diagnostic Substances
[ Wed, Aug 08th 2012 ] - Market Wire
Oncothyreon Announces Second Quarter 2012 Financial Results Conference Call
[ Wed, Aug 08th 2012 ] - Market Wire
AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
[ Wed, Aug 08th 2012 ] - Market Wire
Uroplasty To Participate In Two Upcoming Conferences
[ Wed, Aug 08th 2012 ] - Market Wire
Lorus Therapeutics Reports Results for Fiscal Year 2012
Tue, August 7, 2012
[ Tue, Aug 07th 2012 ] - Market Wire
Theratechnologies Receives Notification from NASDAQ Relating to Minimum Bid Price
[ Tue, Aug 07th 2012 ] - Market Wire
Islet Sciences Announces Strategic Alliance with Spring Point Project
[ Tue, Aug 07th 2012 ] - Market Wire
Hangover Joe's The Hangover Recovery Shot Now Available in Canada
[ Tue, Aug 07th 2012 ] - Market Wire
ProMetic to Report Second Quarter 2012 Financial Results and Hold Conference Call/Webcast
[ Tue, Aug 07th 2012 ] - Market Wire
MiMedx Group Announces Positive Results From Diabetic Foot Ulcer Randomized Controlled Trial
[ Tue, Aug 07th 2012 ] - Market Wire
Corcept Therapeutics Announces $30 Million Synthe .. on;; Terminates Committed Equity Financing
[ Tue, Aug 07th 2012 ] - Market Wire
AspenBio Pharma Submits Pre-IDE Information Packa .. e to FDA for AppyScorea" Appendicitis Test System
[ Tue, Aug 07th 2012 ] - Market Wire
Aeterna Zentaris Granted Patent in the U.S. for A .. agnostic Test for Adult Growth Hormone Deficiency
[ Tue, Aug 07th 2012 ] - Market Wire
Rigel Announces Second Quarter 2012 Financial Results
[ Tue, Aug 07th 2012 ] - Market Wire
EnteroMedics Reports Second Quarter 2012 Financial Results
[ Tue, Aug 07th 2012 ] - Market Wire
Luminex Corporation y el University Hospital of Wales colaboran durante los Juegos Olmpicos
Mon, August 6, 2012
[ Mon, Aug 06th 2012 ] - Market Wire
MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
[ Mon, Aug 06th 2012 ] - Market Wire
ViroPharma Receives FDA Approval of Cinryze (C1 E .. Inhibitor [Human]) Industrial Scale Manufacturing
[ Mon, Aug 06th 2012 ] - Market Wire
Zondan Partners with Masimo to Incorporate Signal .. inbow Across Entire Portfolio of Patient Monitors
[ Mon, Aug 06th 2012 ] - Market Wire
Equity Research on CareFusion Corp. and Stryker C .. arnings Shake Up Medical Instruments and Supplies
[ Mon, Aug 06th 2012 ] - Market Wire
SearchCore Announces Executive Resignations
[ Mon, Aug 06th 2012 ] - Market Wire
Cytomedix Announces Medicare Coverage for Autologous PRP Gel in Chronic Wound Care
[ Mon, Aug 06th 2012 ] - Market Wire
EnteroMedics to Present at 32nd Annual Canaccord Genuity Growth Conference
[ Mon, Aug 06th 2012 ] - Market Wire
Luminex Corporation et l'h'pital universitaire du .. Galles s'associent l'occasion des Jeux olympiques
[ Mon, Aug 06th 2012 ] - Market Wire
ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012
[ Mon, Aug 06th 2012 ] - Market Wire
Savient Pharmaceuticals Adopts Stockholder Rights Plan
[ Mon, Aug 06th 2012 ] - Market Wire
Sunshine Heart Announces Conditional Approval Fro .. for Its Next Generation C-Pulse(R) System Driver
Fri, August 3, 2012
[ Fri, Aug 03rd 2012 ] - Market Wire
Biostar Pharmaceuticals, Inc. Receives Approval F .. ng SFDA To Restart Sales Of Its Gel Capsule Drugs
[ Fri, Aug 03rd 2012 ] - Market Wire
Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA
[ Fri, Aug 03rd 2012 ] - Market Wire
DiaMedica Accelerates Warrant Expiry Date
[ Fri, Aug 03rd 2012 ] - Market Wire
SoloHealth and WellPoint Announce Strategic Relat .. lp Make Consumers More Aware, Empowered & Healthy
[ Fri, Aug 03rd 2012 ] - Market Wire
Gemoscan Canada Announces Convertible Debenture Financing
[ Fri, Aug 03rd 2012 ] - Market Wire
Pro-Dex, Inc. Announces Update Conference Call and Webcast
[ Fri, Aug 03rd 2012 ] - Market Wire
Avanir Pharmaceuticals Announces Listing Of Additional NUEDEXTA Patent In FDA Orange Book
[ Fri, Aug 03rd 2012 ] - Market Wire
Daxor Announces Sale of BVA-100 Blood Volume Analyzer and Payment of a Dividend
[ Fri, Aug 03rd 2012 ] - Market Wire
Bioheart Renegotiates Company Note With Favorable Terms
[ Fri, Aug 03rd 2012 ] - Market Wire
Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry
[ Fri, Aug 03rd 2012 ] - Market Wire
Concord Medical to Report Second Quarter 2012 Financial Results on August 20, 2012
Thu, August 2, 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
Nektar to Announce Financial Results for the Seco .. y, August 9, 2012, After Close of U.S.-Based Fina
[ Thu, Aug 02nd 2012 ] - Market Wire
MSA Declares Third Quarter Dividend
[ Thu, Aug 02nd 2012 ] - Market Wire
Mylan Signs Agreement with Gilead to Accelerate A .. ixed-Dose Combination ARVs Containing Emtricitabi
[ Thu, Aug 02nd 2012 ] - Market Wire
Waters and Nonlinear Dynamics to Co-Develop Next .. arch Solutions for Large-Scale, Complex Data Sets
[ Thu, Aug 02nd 2012 ] - Market Wire
Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
[ Thu, Aug 02nd 2012 ] - Market Wire
Accuray Announces First CyberKnife System in South America
[ Thu, Aug 02nd 2012 ] - Market Wire
ZYTO Corp Announces Expansion of Scientific Advisory Board
[ Thu, Aug 02nd 2012 ] - Market Wire
Bioheart Receives $ 2 Million Term Sheet Investme .. bal Leader in Healthcare in Latin America and Eur
[ Thu, Aug 02nd 2012 ] - Market Wire
Implant Sciences Awarded Follow-On Order to China for Aviation Security
[ Thu, Aug 02nd 2012 ] - Market Wire
00 p.m. EDT
[ Thu, Aug 02nd 2012 ] - Market Wire
Comprehensive Care Corporation Names Colonel Ramo .. Advisor To Maximize its Market Share with New Pha
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ] - Market Wire
Sarepta Therapeutics to Present Company Overview .. e 32nd Canaccord Genuity Annual Growth Conference
[ Wed, Aug 01st 2012 ] - Market Wire
Isis And Collaborators Alleviate Disease In Animal Models Of Myotonic Dystrophy
[ Wed, Aug 01st 2012 ] - Market Wire
Pharmacyclics Triggers Significant Milestone Payment and Provides Clinical Program Update
[ Wed, Aug 01st 2012 ] - Market Wire
Eternity Healthcare Receives Regulatory Approval in Canada for its Needle-Free Injection Device
[ Wed, Aug 01st 2012 ] - Market Wire
Lpath Appoints Daniel L. Kisner, M.D. to Board of Directors
[ Wed, Aug 01st 2012 ] - Market Wire
Head of European Operations
[ Wed, Aug 01st 2012 ] - Market Wire
AcelRx Pharmaceuticals Receives Two Additional U. .. s for Small-Volume Oral Transmucosal Dosage Forms
[ Wed, Aug 01st 2012 ] - Market Wire
Ampio announces successful Pre-IND meeting with t .. the FDA on Optinaa" for the treatment of Diabetic
[ Wed, Aug 01st 2012 ] - Market Wire
Die Familie der INGENIO-Herzschrittmacher erhlt die CE-Kennzeichnung fr den Einsatz bei MRT-Scans
[ Wed, Aug 01st 2012 ] - Market Wire
La famiglia di pacemaker INGENIO di Boston Scient .. er la sua compatibilit con la risonanza magnetica
[ Wed, Aug 01st 2012 ] - Market Wire
La familia de marcapasos INGENIO de Boston Scient .. ra su uso durante las pruebas de resonancia magnt
Tue, July 31, 2012
[ Tue, Jul 31st 2012 ] - Market Wire
Pharming Secures EUR10 Million Working Capital Facility From Existing Investors
[ Tue, Jul 31st 2012 ] - Market Wire
New York Genome Center Purchases Four Ion Protona" Sequencers for its new Innovation Center
[ Tue, Jul 31st 2012 ] - Market Wire
Fresh Start Private Announces New Web Presence
[ Tue, Jul 31st 2012 ] - Market Wire
China Cord Blood Corporation Files its Annual Report on Form 20-F
[ Tue, Jul 31st 2012 ] - Market Wire
Zynex Schedules Second Quarter 2012 Earnings Release and Webcast
[ Tue, Jul 31st 2012 ] - Market Wire
Aethlon Medical Reports Undetectable Hepatitis C .. Initiation of Hemopurifier Therapy in Genotype-1
[ Tue, Jul 31st 2012 ] - Market Wire
CMC Biologics Acquires XOMA's Bay Area Manufacturing Facility
[ Tue, Jul 31st 2012 ] - Market Wire
La Jolla Pharmaceutical Company Announces FDA Agr .. Clinical Trial of GCS-100 in Chronic Kidney Disea
[ Tue, Jul 31st 2012 ] - Market Wire
Omeros Announces Discovery in MASP-2 Program
[ Tue, Jul 31st 2012 ] - Market Wire
FDA Accepts NuPathe's Migraine Patch NDA Resubmission for Filing
[ Tue, Jul 31st 2012 ] - Market Wire
Novadaq to Present at the Canaccord Genuity 32nd Annual Growth Conference
Mon, July 30, 2012
[ Mon, Jul 30th 2012 ] - Market Wire
Acura Pharmaceuticals Announces Second Quarter 2012 Financial Results
[ Mon, Jul 30th 2012 ] - Market Wire
Sanofi Pasteur to add 2D barcode to six more vaccines
[ Mon, Jul 30th 2012 ] - Market Wire
CFA Commentary on Sunshine Biopharma, Inc. (OTCBB: SBFM)
[ Mon, Jul 30th 2012 ] - Market Wire
New Published Paper Shows Efficacy of Lpath's Ant .. Antibody, Lpathomab, in Spinal Cord Injury Models
[ Mon, Jul 30th 2012 ] - Market Wire
Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
[ Mon, Jul 30th 2012 ] - Market Wire
Equity Research on Forest Laboratories Inc. and E .. atent Expiries and New Releases Lead to Mixed Res
[ Mon, Jul 30th 2012 ] - Market Wire
USANA Health Sciences Continues to Reduce its Carbon Footprint
[ Mon, Jul 30th 2012 ] - Market Wire
ProMetic Life Sciences and NantPharma, a NantWork .. d Commercialize Plasma-Derived Biopharmaceuticals
[ Mon, Jul 30th 2012 ] - Market Wire
OncoSec Receives ISO 13485 Quality Management System Certification
[ Mon, Jul 30th 2012 ] - Market Wire
Comprehensive Care Corporation Retained by CHRIST .. to Provide Behavioral Health Management Services
[ Mon, Jul 30th 2012 ] - Market Wire
Eisai and Arena Pharmaceuticals Complete Transfer of BELVIQ (lorcaserin HCl) New Drug Application
Sun, July 29, 2012
[ Sun, Jul 29th 2012 ] - Market Wire
Basilea submits European Marketing Authorization .. on of ceftobiprole for the treatment of pneumonia
[ Sun, Jul 29th 2012 ] - Market Wire
Clinical Research on Accuray's CyberKnife and Tom .. nted at Key Industry Event for Medical Physicists
Fri, July 27, 2012
[ Fri, Jul 27th 2012 ] - Market Wire
Harvard and MIT Students Rally Boston to Join Glo .. nness World Record Attempt on World Hepatitis Day
[ Fri, Jul 27th 2012 ] - Market Wire
Ellen M. Zane Joins Haemonetics Board of Directors
[ Fri, Jul 27th 2012 ] - Market Wire
Bacterin International Holdings, Inc. Schedules S .. d Quarter 2012 Financial Earnings Conference Call
[ Fri, Jul 27th 2012 ] - Market Wire
Insulet Corporation to Report Second Quarter 2012 Financial Results on August 8, 2012
[ Fri, Jul 27th 2012 ] - Market Wire
Sarepta Therapeutics Regains NASDAQ Compliance
[ Fri, Jul 27th 2012 ] - Market Wire
Equity Research on WellPoint Inc. and CIGNA Corp. - Tough Times for Insurers
[ Fri, Jul 27th 2012 ] - Market Wire
Santa Fe Petroleum, Inc. Announces the Appointmen .. om Griffin as President and Chairman of the Board
[ Fri, Jul 27th 2012 ] - Market Wire
Hansen Medical Announces Second Quarter 2012 Results Conference Call
[ Fri, Jul 27th 2012 ] - Market Wire
Micro Imaging Technology Introduces the MIT 1000 to Food Safety Industry Professionals
[ Fri, Jul 27th 2012 ] - Market Wire
Aethlon Medical Announces the Appointment of Thom .. nham and Philip A. Ward to its Board of Directors
[ Fri, Jul 27th 2012 ] - Market Wire
Mylan Launches Generic Version of Sporanox Capsules
Thu, July 26, 2012
[ Thu, Jul 26th 2012 ] - Market Wire
NuPathe Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
[ Thu, Jul 26th 2012 ] - Market Wire
Once-Daily Dolutegravir is Non-Inferior to Twice- .. Raltegravir in Treatment-Naive Adults with HIV-1
[ Thu, Jul 26th 2012 ] - Market Wire
Securities Lawyers at Goldfarb LLP Seeking More M .. n for Stockholders of Human Genome Sciences, Inc.
[ Thu, Jul 26th 2012 ] - Market Wire
BD and PEPFAR Launch Labs for Life to Strengthen .. boratories in Regions Heavily Burdened by Disease
[ Thu, Jul 26th 2012 ] - Market Wire
Merck Recognizes World Hepatitis Day With Partner .. o Support Global and U.S. Hepatitis C Communities
[ Thu, Jul 26th 2012 ] - Market Wire
Notice of Paladin Labs' Second Quarter 2012 Results Conference Call
[ Thu, Jul 26th 2012 ] - Market Wire
Unigene Provides Update Following Recent EMA Recommendation on Calcitonin-Containing Medicines
[ Thu, Jul 26th 2012 ] - Market Wire
Cytori to Webcast Second Quarter Financial Results on August 8
[ Thu, Jul 26th 2012 ] - Market Wire
Preclinical Data for AEZS-108 in Bladder Cancer Published Online in Oncotarget
[ Thu, Jul 26th 2012 ] - Market Wire
Digirad Corporation Reports 2012 Second Quarter and Six-Month Financial Results
[ Thu, Jul 26th 2012 ] - Market Wire
Alimera Sciences' ILUVIEN Receives Marketing Auth .. r the Treatment of Chronic Diabetic Macular Edema
Wed, July 25, 2012
[ Wed, Jul 25th 2012 ] - Market Wire
MELA Sciences to Release Second Quarter Financial .. d Host Conference Call on Tuesday, August 7, 2012
[ Wed, Jul 25th 2012 ] - Market Wire
Quick-Med Receives Patent for Enhancing the Antim .. ce of NIMBUS(R) Contact Lenses and Other Surfaces
[ Wed, Jul 25th 2012 ] - Market Wire
BIOLASE Establishes Inside Sales Group
[ Wed, Jul 25th 2012 ] - Market Wire
Genomic Health Announces Publication of Clinical .. marker Discovery Using Next Generation Sequencing
[ Wed, Jul 25th 2012 ] - Market Wire
NuPathe Appoints Armando Anido as Chief Executive Officer
[ Wed, Jul 25th 2012 ] - Market Wire
EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
[ Wed, Jul 25th 2012 ] - Market Wire
Acura Pharmaceuticals to Host Second Quarter 2012 .. nancial Results Conference Call on August 8, 2012
[ Wed, Jul 25th 2012 ] - Market Wire
Implant Sciences Wins Contracts to Supply Additio .. s to China for Use by China Police and Bomb Squad
[ Wed, Jul 25th 2012 ] - Market Wire
EnteroMedics to Host Second Quarter 2012 Financia .. sults Conference Call and Provide Business Update
[ Wed, Jul 25th 2012 ] - Market Wire
STATS ChipPAC Appoints Gary Tanner as Director
[ Wed, Jul 25th 2012 ] - Market Wire
Sunshine Heart Announces CE Mark for C-Pulse(R) Heart Assist System
Tue, July 24, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
ViroPharma To Release 2012 Second Quarter Financial Results On August 9, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Almirall et Forest Laboratories annoncent l'appro .. a" Pressaira" pour le traitement d'entretien long
[ Tue, Jul 24th 2012 ] - Market Wire
Anthera Pharmaceuticals Announces Exercise in Ful .. and Completion of Public Offering of Common Stock
[ Tue, Jul 24th 2012 ] - Market Wire
Winner Medical Enters into Definitive Merger Agreement with Winner Holding Limited
[ Tue, Jul 24th 2012 ] - Market Wire
BIOLASE Announces Opening of Corporate Technology and Training Center
[ Tue, Jul 24th 2012 ] - Market Wire
Rosetta Genomics and Precision Therapeutics Enter .. Co-Marketing Agreement for miRview mets(2) Assay
[ Tue, Jul 24th 2012 ] - Market Wire
Neogen reports year end results
[ Tue, Jul 24th 2012 ] - Market Wire
Nephros Announces Expansion of U.S. Sales Team
[ Tue, Jul 24th 2012 ] - Market Wire
Auxilium Pharmaceuticals to Announce Second Quart .. Conduct Conference Call on Tuesday, July 31, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Enzalutamide Granted Priority Review by U.S. FDA .. f Castration-Resistant Prostate Cancer in Patient
[ Tue, Jul 24th 2012 ] - Market Wire
Sarepta Therapeutics Announces Significant Clinic .. ter 36 Weeks in Phase IIb Study for the Treatment
Mon, July 23, 2012
[ Mon, Jul 23rd 2012 ] - Market Wire
Sanofi US Launches Collaborate Activate Innovation Challenge
[ Mon, Jul 23rd 2012 ] - Market Wire
Sarepta Announces Conference Call and Webcast on .. scuss 36-Week 6-Minute Walk Test Results From the
[ Mon, Jul 23rd 2012 ] - Market Wire
Savient Pharmaceuticals Receives Favorable Decision In Tang Capital Litigation
[ Mon, Jul 23rd 2012 ] - Market Wire
Ronald L. Chez Files Amended 13D and Letter to the Board
[ Mon, Jul 23rd 2012 ] - Market Wire
Sunshine Heart Announces First Patient Reaches Tw .. Follow-Up Mark for C-Pulse(R) Heart Assist System
[ Mon, Jul 23rd 2012 ] - Market Wire
Implant Sciences Extends Global Distribution Network Into Switzerland
[ Mon, Jul 23rd 2012 ] - Market Wire
InternetArray Appoints StockPlay Director of Marketing
[ Mon, Jul 23rd 2012 ] - Market Wire
Mexico Grants Quick-Med Technologies Additional NIMBUS(R) Patent
[ Mon, Jul 23rd 2012 ] - Market Wire
Life Technologies Develops Simplified SAME-DAY ST .. ecting Multiple Strains of E. coli in Ground Beef
[ Mon, Jul 23rd 2012 ] - Market Wire
Trimel Completes Patient Enrolment of CompleoTRT(TM) Phase III Trial
[ Mon, Jul 23rd 2012 ] - Market Wire
BioLife Solutions Completes Corporate Facilities .. of Additional cGMP Clean Room Manufacturing Suite
Sun, July 22, 2012
[ Sun, Jul 22nd 2012 ] - Market Wire
Basilea announces completion of Toctino(R) (alitretinoin) transaction with Stiefel
Sat, July 21, 2012
[ Sat, Jul 21st 2012 ] - Market Wire
Faruqi & Faruqi, LLP Encourages Investors Who Suf .. 0,000 Investing in Centene Corporation To Contact
Fri, July 20, 2012
[ Fri, Jul 20th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. cess of $100,000 Investing in Centene Corporation
[ Fri, Jul 20th 2012 ] - Market Wire
AcelRx Pharmaceuticals, Inc. Investor Presentatio .. n-demand Viewing at RetailInvestorConferences.com
[ Fri, Jul 20th 2012 ] - Market Wire
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolisa" (carfilzomib) for Injection
[ Fri, Jul 20th 2012 ] - Market Wire
Positron Accepts Economic Incentives Offer From T .. For $30 Million Towards 70 MeV Cyclotron Project
[ Fri, Jul 20th 2012 ] - Market Wire
CONMED Corporation and Exactech to Partner in Nor .. Medical Education Programs to Treat the Continuum
[ Fri, Jul 20th 2012 ] - Market Wire
Equity Research on DaVita Inc. and HEALTHSOUTH Co .. pecialized Health Providers Enjoying Grace Period
[ Fri, Jul 20th 2012 ] - Market Wire
Arena Pharmaceuticals and VIVUS Competitors in the Lucrative Anti-Obesity Drug Market
[ Fri, Jul 20th 2012 ] - Market Wire
Competition in the Anti-Obesity Drug Market Growi .. as FDA Approves Second Weight Loss Drug This Year
Thu, July 19, 2012
[ Thu, Jul 19th 2012 ] - Market Wire
Amerigroup Honored by American Red Cross
[ Thu, Jul 19th 2012 ] - Market Wire
Whiteknight Acquisitions Inc. Announces Commencem .. sing of Its Qualifying Transaction and Concurrent
[ Thu, Jul 19th 2012 ] - Market Wire
Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
[ Thu, Jul 19th 2012 ] - Market Wire
Thallion Announces Sale of its Stake in Caprion Proteomics
[ Thu, Jul 19th 2012 ] - Market Wire
Gentiva Health Services Schedules Second Quarter .. ngs Call And Webcast For Thursday, August 2, 2012
[ Thu, Jul 19th 2012 ] - Market Wire
Sarepta's Marburg Virus Drug Shows Survival in Primates Despite Delayed Treatment
[ Thu, Jul 19th 2012 ] - Market Wire
ImmuCell Receives Effectiveness Technical Section Complete Letter From FDA for Mast Out(R)
[ Thu, Jul 19th 2012 ] - Market Wire
Life Technologies Signs Collaborative Agreement w .. rtium to Develop First Antibody Master Set for Ep
[ Thu, Jul 19th 2012 ] - Market Wire
Helix BioPharma Corp. Announces Filing of Form 15F to Terminate SEC Reporting Obligations
[ Thu, Jul 19th 2012 ] - Market Wire
PDL BioPharma to Announce Second Quarter 2012 Financial Results on August 2, 2012
Wed, July 18, 2012
[ Wed, Jul 18th 2012 ] - Market Wire
Alexza Announces Submission of Responses to the E .. A Day 120 List of Questions for the ADASUVEa" MAA
[ Wed, Jul 18th 2012 ] - Market Wire
Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
[ Wed, Jul 18th 2012 ] - Market Wire
Sangamo BioSciences Announces Second Quarter 2012 Conference Call and Webcast
[ Wed, Jul 18th 2012 ] - Market Wire
Cynapsus Announces Closing of Private Placement
[ Wed, Jul 18th 2012 ] - Market Wire
Cytomedix Announces Collaboration With Duke Unive .. e I Clinical Study of ALD-451 in Malignant Glioma
[ Wed, Jul 18th 2012 ] - Market Wire
Neogen Corporation Announces Year-End Results Conference Call
[ Wed, Jul 18th 2012 ] - Market Wire
Life Technologies Moving quot;;Off the Gridquot;; with Clean Energy Fuel Cells
[ Wed, Jul 18th 2012 ] - Market Wire
Uroplasty Announces Coverage Of Percutaneous Tibi .. s Urgent PC Neuromodulation System From EmblemHea
[ Wed, Jul 18th 2012 ] - Market Wire
Titan Medical Inc. Announces Issuance of U.S. Patent
[ Wed, Jul 18th 2012 ] - Market Wire
ViiV Healthcare Expands Commitment to Addressing .. ps in Paediatric HIV Research, Care and Treatment
Tue, July 17, 2012
[ Tue, Jul 17th 2012 ] - Market Wire
Baker Brothers notify of 6.5% shareholding in Galapagos
[ Tue, Jul 17th 2012 ] - Market Wire
3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
[ Tue, Jul 17th 2012 ] - Market Wire
Select Medical Holdings Corporation to Announce Second Quarter 2012 Results on Tuesday, August 7
[ Tue, Jul 17th 2012 ] - Market Wire
Skilled Healthcare to Release Second Quarter 2012 Results on August 8, 2012
[ Tue, Jul 17th 2012 ] - Market Wire
The Lin Law Firm Investigates Potential Breaches .. tion With Proposed Acquisition of Par Pharmaceuti
[ Tue, Jul 17th 2012 ] - Market Wire
Remedent Reports Fourth Quarter and Year End Resu .. ference Call at 12 PM EDT, Tuesday, July 17, 2012
[ Tue, Jul 17th 2012 ] - Market Wire
BMR Previews Earnings for Intuitive Surgical, eBay, Chipotle, Kinder Morgan amp;; Others
[ Tue, Jul 17th 2012 ] - Market Wire
Three More Leading Medical Centres Join VentriPoi .. entre Clinical Trial for Congenital Heart Disease
[ Tue, Jul 17th 2012 ] - Market Wire
Soligenix Announces $600,000 NIAID SBIR Grant Awa .. ion of OrbeShielda" as a Treatment for Acute Radi
[ Tue, Jul 17th 2012 ] - Market Wire
China Health Resource Develops Revolutionary Migraine Medication
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
Sequenom, Inc. Files Notice Of Appeal Of Preliminary Injunction Denial
[ Mon, Jul 16th 2012 ] - Market Wire
NuPathe Announces Migraine Patch NDA Resubmission
[ Mon, Jul 16th 2012 ] - Market Wire
Amerigroup Foundation Provides $50,000 Grant to Improve Access to Care in Rural Georgia
[ Mon, Jul 16th 2012 ] - Market Wire
Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012

Peregrine Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement


//health-fitness.news-articles.net/content/2012/ .. asdaq-minimum-bid-price-listing-requirement.html
Published in Health and Fitness on Monday, July 30th 2012 at 9:48 GMT by Market Wire   Print publication without navigation


July 30, 2012 12:42 ET

Peregrine Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement

TUSTIN, CA--(Marketwire - Jul 30, 2012) -  Peregrine Pharmaceuticals (NASDAQ: [ PPHM ]) today announced that it has received a letter from The NASDAQ Stock Market LLC notifying the company that it has regained full compliance with the NASDAQ Capital Market's minimum bid price continued listing requirement, as a result of the closing bid price of its common stock having been at or above the minimum requirement of $1.00 per share for at least 10 consecutive trading days. As a result, Peregrine's shares of common stock will continue to trade on the NASDAQ capital market.

About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and infectious diseases. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. ([ www.avidbio.com ]), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at [ www.peregrineinc.com ]. 



Publication Contributing Sources